logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12103958 B1

PDFFull Text
Date of Patent:
Oct. 01, 2024

Filed:

Sep. 28, 2020

Lymphocyte function-associated antigen 3 (lfa3) variant polypeptides and methods of use thereof to treat cd2-mediated immune diseases, disorders or conditions

Applicants:

Pfizer Inc., New York, NY (US);

The Regents of the University of California, Oakland, CA (US);

Inventors:

Natasha Kay Crellin, New York, NY (US);

Lauren Kate Ely, New York, NY (US);

Jason Robles Reyes, New York, NY (US);

Chia Chi Ho, New York, NY (US);

Jeffrey A. Bluestone, Oakland, CA (US);

Eleonora Trotta, Oakland, CA (US);

Qizhi Tang, Oakland, CA (US);

Assignees:

Pfizer Inc., New York, NY (US);

The Regents of the University of California, Oakland, CA (US);

Attorney:

Kilpatrick Townsend & Stockton LLP

Primary Examiner:

Robert S Landsman

Int. Cl.
CPC ...
C07K 14/705 (2006.01); A61K 39/00 (2006.01); C12N 15/63 (2006.01); G01N 33/50 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70528 (2013.01); A61K 39/001129 (2018.08); C12N 15/63 (2013.01); G01N 33/505 (2013.01); G01N 33/68 (2013.01); C07K 2319/30 (2013.01); G01N 2333/70507 (2013.01);
Abstract

The invention provides LFA3 polypeptide molecules, e.g., variant LFA3 fusion polypeptide molecules. The invention includes uses, and associated methods of using the LFA3 polypeptide molecules.

Find Patent Forward Citations

Quick Actions:

Crellin, Natasha. (2024). Lymphocyte function-associated antigen 3 (lfa3) variant polypeptides and methods of use thereof to treat cd2-mediated immune diseases, disorders or conditions (U.S. Patent No. 12103958). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12103958

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…